Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 3/20 | 0.53 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.50 |
| ▸ | RECQL | P46063 | 4/20 | 0.50 |
| ▸ | CASP6 | P55212 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.50 |
| ▸ | NSD2 | O96028 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.50 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.49 |
| ▸ | HPGD | P15428 | 3/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14576111 | 0.98 | NT5E (0.51) | NT5ERAPGEF4ALDH1A1TDP1RECQL | |
| SCHEMBL9367132 | 0.84 | CA1 (0.47) | NT5ERAPGEF4ALDH1A1TDP1RECQL | |
| SCHEMBL17774548 | 0.84 | L3MBTL1 (0.48) | NT5ERAPGEF4ALDH1A1TDP1RECQL | |
| Hydrochloric Acid SCHEMBL18301892 | 0.83 | CA1 (0.45) | NT5ERAPGEF4ALDH1A1TDP1RECQL | |
| SCHEMBL158793 | 0.83 | NT5E (0.53) | NT5ERAPGEF4ALDH1A1TDP1RECQL | |
| SCHEMBL7511717 | 0.82 | RAPGEF4 (0.56) | NT5ERAPGEF4ALDH1A1TDP1RECQL | |
| Sulfuric Acid SCHEMBL6251886 | 0.82 | L3MBTL1 (0.53) | NT5ERAPGEF4ALDH1A1TDP1RECQL | |
| SCHEMBL7051361 | 0.81 | L3MBTL1 (0.57) | NT5ERAPGEF4ALDH1A1TDP1RECQL | |
| SCHEMBL29349546 | 0.80 | ALDH1A1 (0.55) | NT5ERAPGEF4ALDH1A1TDP1RECQL | |
| SCHEMBL7099533 | 0.80 | RAPGEF4 (0.55) | NT5ERAPGEF4ALDH1A1TDP1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 337 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106669627-B | A kind of adsorption composite material and preparation method thereof | 苏州欢颜电气有限公司 | 2019-07-16 | — | — | CN | claimed |
| US-20240131109-A1 | STABLE ASCORBIC ACID COMPOSITIONS AND METHODS OF USING SAME | RENOVION, INC. | 2024-04-25 | — | — | US | disclosed |
| US-11938166-B2 | Methods and compositions for treating mucosal tissue disorders | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2024-03-26 | — | — | US | disclosed |
| US-11890315-B2 | Stable ascorbic acid compositions and methods of using same | RENOVION, INC. (US) | 2024-02-06 | — | — | US | disclosed |
| WO-2024016019-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF SUBJECTS SUFFERING FROM A SARS-COV-2 INFECTION | RENOVION, INC. (US) | 2024-01-18 | — | — | WO | disclosed |
| US-20230165929-A1 | TREATMENT OF RESPIRATORY TRACT DISEASES AND INFECTIONS WITH ASCORBIC ACID COMPOSITIONS | RENOVION, INC. | 2023-06-01 | — | — | US | disclosed |
| US-20230144527-A1 | STABLE ASCORBIC ACID COMPOSITIONS AND METHODS OF USING SAME | RENOVION, INC. | 2023-05-11 | — | — | US | disclosed |
| US-11602555-B2 | Treatment of respiratory tract diseases and infections with ascorbic acid compositions | RENOVION, INC. (US) | 2023-03-14 | — | — | US | disclosed |
| US-20220143129-A1 | METHODS AND COMPOSITIONS FOR TREATING MUCOSAL TISSUE DISORDERS | UNIV NORTH CAROLINA CHAPEL HILL (US) | 2022-05-12 | — | — | US | disclosed |
| US-11058743-B2 | Methods and compositions for treating mucosal tissue disorders | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2021-07-13 | — | — | US | disclosed |
| US-4474697-A | DYEING COTTON | BAYER AKTIENGESELSCHAFT (DE) | 1984-10-02 | — | — | US | disclosed |
| EP-0084314-A2 | Reactive disazo dyes | BAYER AG (DE) | 1983-07-27 | — | — | EP | disclosed |
| EP-0013879-B1 | REACTIVE DYESTUFFS, THEIR PREPARATION AND THEIR USE FOR DYEING MATERIALS CONTAINING HYDROXYL OR AMIDE GROUPS | BAYER AG (DE) | 1982-09-15 | — | — | EP | disclosed |
| US-4270010-A | HEATING AN AQUEOUS SOLUTION OF P-AMINOPHENOL OR A SALT WITH AN ORGANIC SULFONIC ACID; SOLVENT EXTRACTION; FROM NITROBENZENE REDUCTION | ELPROCHINE AG (CH) | 1981-05-26 | — | — | US | disclosed |
| EP-0015876-A1 | Process for the production of hydroquinone | ELPROCHINE AG (CH) | 1980-09-17 | — | — | EP | disclosed |
| EP-0013879-A1 | Reactive dyestuffs, their preparation and their use for dyeing materials containing hydroxyl or amide groups | BAYER AG (DE) | 1980-08-06 | — | — | EP | disclosed |
| US-4209459-A | USEFUL FOR ASSAY OF LEUCIN-AMINOPEPTIDASE ACTIVITY | NITTO BOSEKI CO., LTD. (JP) | 1980-06-24 | — | — | US | disclosed |
| US-4104021-A | OXIDATION COLOR DYES | COMBE INCORPORATED (US) | 1978-08-01 | — | — | US | disclosed |
| US-4010150-A | Red copper complexes of disazo compounds containing triazine groups | NIPPON KAYAKU KABUSHIKI KAISHA (JA) | 1977-03-01 | — | — | US | disclosed |
| US-3977826-A | HYDROGEN PEROXIDE, OXIDATION DYE COMPONENTS | CLAIROL INCORPORATED (US) | 1976-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11890315-B2 | Stable ascorbic acid compositions and methods of using same | GPX1, GSTA1, GPX4 | NT5E 2961/4885RAPGEF4 2925/4885ALDH1A1 93/4885 |
| US-20230165929-A1 | TREATMENT OF RESPIRATORY TRACT DISEASES AND INFECTIONS WITH ASCORBIC ACID COMPOSITIONS | GPX1, GPX4, GSR | NT5E 1901/4885RAPGEF4 3468/4885ALDH1A1 365/4885 |
| US-11602555-B2 | Treatment of respiratory tract diseases and infections with ascorbic acid compositions | GPX1, GPX4, GSR | NT5E 1901/4885RAPGEF4 3468/4885ALDH1A1 365/4885 |
| US-20240131109-A1 | STABLE ASCORBIC ACID COMPOSITIONS AND METHODS OF USING SAME | GPX1, GSTA1, GPX4 | NT5E 2961/4885RAPGEF4 2925/4885ALDH1A1 93/4885 |
| US-20230144527-A1 | STABLE ASCORBIC ACID COMPOSITIONS AND METHODS OF USING SAME | GPX1, GSTA1, GPX4 | NT5E 2961/4885RAPGEF4 2925/4885ALDH1A1 93/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.